Roth MKM lowered the firm’s price target on Allurion Technologies (ALUR) to $16 from $50 and keeps a Buy rating on the shares. The firm is ...

Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for Allurion Technologies in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst J. Wittes now ...

Allurion launched an AI-powered GLP-1 programme that offers virtual insights to muscle and bone mass. Just over a year after going public on the New York Stock Exchange, the company received a ...

In a report released today, Jason Wittes from Roth MKM maintained a Buy rating on Allurion Technologies (ALUR – Research Report), with a price ...

--(BUSINESS WIRE)-- Allurion Technologies ... for the purchase and sale of 900,000 shares of the Company’s common stock at a price of $5.23 per share and warrants to purchase up to 1,800,000 ...

In addition, in a concurrent private placement, the Company will issue to the investors warrants to purchase up to 1,240,000 shares of common stock ... documents filed by Allurion from time to time ...

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric ...

(RTTNews) - Allurion Technologies ... ALUR is currently trading at $2.695 or 8.02% lower on the New York Stock Exchange. The views and opinions expressed herein are the views and opinions of ...

NATICK, Mass., February 18, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity ...

2024 and other documents filed by Allurion from time to time with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could ...